Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Jul 2021 – 20 Aug 2026, limited by Axis Quant Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Quant Fund | Nifty 500 |
|---|---|---|
| 07 Jul 2021 | ₹100.00 | ₹100.00 |
| 10 Dec 2021 | ₹110.20 | ₹111.18 |
| 15 May 2022 | ₹95.45 | ₹98.83 |
| 18 Oct 2022 | ₹109.60 | ₹110.46 |
| 22 Mar 2023 | ₹104.06 | ₹106.08 |
| 25 Aug 2023 | ₹122.08 | ₹123.40 |
| 28 Jan 2024 | ₹142.87 | ₹142.27 |
| 02 Jul 2024 | ₹162.77 | ₹166.37 |
| 05 Dec 2024 | ₹163.17 | ₹170.77 |
| 10 May 2025 | ₹147.82 | ₹159.02 |
| 12 Oct 2025 | ₹155.05 | ₹171.21 |
| 17 Mar 2026 | ₹145.25 | ₹158.97 |
| 20 Aug 2026 | ₹161.39 | ₹172.50 |
| Metric | Axis · Regular NAV ₹16.30 Very High risk ★☆☆☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +4.49% | +5.83% | |
| +9.76% | +15.63% | |
| +9.49% | +13.23% | |
| — | +13.85% | |
| +9.80% | +12.26% | |
| +8.66% | — | |
| +13.23% | +15.60% | |
| +9.73% | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 14.53% | 15.62% | |
| 0.22 | 0.43 | |
| 0.30 | 0.59 | |
| -23.47% | -23.65% | |
| Nifty 500 | — | |
| -1.67% | +3.42% | |
| 1.02 | 0.95 | |
| 98.0% | 105.9% | |
| 108.1% | 93.6% | |
| 4.18% | 2.39% | |
| ₹826.86Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 27% | 45% | |
| Karthik Kumar | — | |
| 07 Jul 2021 | — | |
| 25 | — | |
| 38.4% | — | |
| -6.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.